Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиAgeX Therapeutics Мультипликаторы 2011-2024 | AGE
Мультипликаторы по годам AgeX Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.0 | -3.5 | 32.8 | -4.3 | -18.3 | - | -8.5 | - | - | - | - | - |
P/S |
0.1 | 0.0 | 211.3 | 35.1 | 30.4 | 98.3 | - | 79.2 | - | - | - | - | - |
EPS |
-13.7 | -9.7 | -0.2 | -0.3 | -0.3 | -0.2 | -0.2 | - | - | - | - | - | - |
EV (Enterprise Value) |
6.28 млн | 19.9 млн | 44.9 млн | 74.3 млн | 55 млн | 133 млн | -6.06 млн | 132 млн | - | - | - | - | - |
EBITDA per Share |
-9.04 тыс. | -6.34 тыс. | -0.21 | -0.25 | -0.311 | -0.307 | - | - | - | - | - | - | - |
EV/EBITDA |
-1.9 | -7.1 | -4.5 | -12.2 | - | -6.8 | - | - | - | - | - | ||
PEG |
- | -0.51 | 0.08 | 1.28 | - | 40.66 | - | - | - | - | - | ||
P/B |
0.0 | -0.0 | -2.6 | -12.1 | 20.1 | 16.7 | - | -5.6 | - | - | - | - | - |
P/CF |
-0.0 | -0.0 | -3.9 | -8.4 | -4.9 | -13.9 | - | -15.6 | - | - | - | - | - |
ROE % |
-270.67 | 60.78 | 73.32 | -37.06 | -464.42 | -91.14 | - | 66.15 | - | - | - | - | - |
ROA % |
-123.72 | -322.80 | -275.05 | 50.96 | -163.32 | -70.30 | - | -480.67 | - | - | - | - | - |
ROCE % |
-180.78 | 40.52 | 67.05 | 187.18 | -302.99 | -136.62 | - | 77.56 | - | - | - | - | - |
Current Ratio |
1.8 | 0.2 | 0.2 | 0.4 | 1.2 | 3.2 | - | 0.0 | - | - | - | - | - |
DSO |
78.4 | 155.7 | 444.8 | 67.3 | 76.7 | 34.3 | - | 67.5 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
9038.3 | 10683.3 | 9163.4 | 8289.7 | 1973.1 | 1165.2 | - | 313.4 | - | - | - | - | - |
Операционный цикл |
78.4 | 155.7 | 444.8 | 67.3 | 76.7 | 34.3 | - | 67.5 | - | - | - | - | - |
Финансовый цикл |
-8959.9 | -10527.6 | -8718.6 | -8222.4 | -1896.4 | -1130.9 | - | -245.9 | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально AgeX Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.14 | -0.07 | - | - | -0.06 | -0.07 | -0.07 | - | -0.05 | -0.07 | -0.06 | - | -0.07 | -0.07 | -0.08 | - | -0.09 | -0.08 | -0.09 | - | -0.06 | -0.06 | -0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-61.2 | -48.9 | -0.06 | - | -40 | -41.1 | -0.05 | - | -0.04 | -57.2 | -0.05 | - | -0.06 | -0.06 | -0.07 | - | -84 | -0.09 | -86.1 | - | -60.9 | -0.06 | -0.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
64.20 | 60.66 | 68.36 | 59.16 | 78.75 | 82.27 | 92.36 | 83.87 | 133.57 | 163.69 | 94.76 | 72.91 | -72.31 | -267.24 | -367.42 | -425.74 | -454.63 | -338.29 | -224.94 | -57.96 | -57.96 | -29.07 | -3.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-213.39 | -290.42 | -370.19 | -322.41 | -402.96 | -362.25 | -358.10 | -243.99 | -308.78 | -293.02 | -144.70 | -95.03 | -138.31 | -116.80 | -209.27 | -126.89 | -147.05 | -123.92 | -100.50 | -40.45 | -40.45 | -20.29 | -2.20 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
38.14 | 39.82 | 43.31 | 39.93 | 56.71 | 63.25 | 77.84 | 79.44 | 126.29 | 156.37 | 176.07 | 151.94 | 4.10 | -190.59 | -392.06 | -443.78 | -473.35 | -355.08 | -228.55 | -105.91 | -105.91 | -76.34 | -47.68 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
3.1 | 0.4 | 0.4 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 1.5 | 1.5 | 1.5 | 1.5 | 4.4 | 4.4 | 4.4 | 4.4 | 7.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
49.7 | 60.8 | 45.6 | - | 65.9 | 45.6 | 228.1 | - | 66.5 | 72.8 | 304.7 | - | 431.1 | 661.1 | 353.2 | - | 80.6 | 87.2 | 58.1 | - | 31.5 | 25.8 | 45.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
2320.0 | 11068.6 | 58171.9 | - | 4672.0 | 5034.0 | 31663.8 | - | 15215.9 | 2993.7 | 17200.6 | - | 4084.8 | 23147.1 | 53883.1 | - | 782.1 | 723.1 | 412.8 | - | -3421.9 | 173.3 | 94.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
49.7 | 60.8 | 45.6 | - | 65.9 | 45.6 | 228.1 | - | 66.5 | 72.8 | 304.7 | - | 431.1 | 661.1 | 353.2 | - | 80.6 | 87.2 | 58.1 | - | 31.5 | 25.8 | 45.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
-2270.2 | -11007.8 | -58126.3 | - | -4606.1 | -4988.3 | -31435.6 | - | -15149.4 | -2920.9 | -16895.9 | - | -3653.7 | -22486.0 | -53529.9 | - | -701.5 | -635.9 | -354.7 | - | 3453.3 | -147.5 | -48.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD